Paris - 28.05.2026: In a significant development for obesity treatment in France, Health Minister Stéphanie Rist announced today that the drugs Wegovy and Mounjaro will now be reimbursed. This decision marks an important step in combating obesity, which affects more than eight million people in France.Wegovy, a drug from the Danish pharmaceutical company Novo Nordisk, had not been reimbursed in France since its introduction in October 2024, costing patients between 274 and 365 euros per month. With the new reimbursement policy, the price for the first three doses is set ...
News subscription
The full article is part of the France Premium News subscription. You can read the opening here; please sign in or choose a News subscription for the full text and the three-day overview.